A rating of 62 puts Lyell Immunopharma Inc (LYEL) near the middle of the Biotechnology industry according to InvestorsObserver. Lyell Immunopharma Inc's score of 62 means it scores higher than 62% of stocks in the industry. Lyell Immunopharma Inc also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 49 out of the 148 industries.
LYEL has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on LYEL!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Lyell Immunopharma Inc Stock Today?
Lyell Immunopharma Inc (LYEL) stock is trading at $2.09 as of 12:16 PM on Wednesday, Nov 15, a gain of $0.19, or 9.74% from the previous closing price of $1.90. The stock has traded between $1.82 and $2.17 so far today. Volume today is below average. So far 559,833 shares have traded compared to average volume of 922,206 shares.
Click Here to get the full Stock Report for Lyell Immunopharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
